Ukko
About Ukko
Ukko is a biotech company improving the lives of millions that suffer from food allergies and disorders. The company's computational engineering platform re-designs food allergens into safe and effective therapeutics that will become best-in-class allergy therapy. Ukko is creating a comprehensive, clinically validated map of the molecular structure of food allergies, revealing critical information about the biological mechanisms that govern human-food interactions. They use the platform to create new versions of proteins that do not elicit an immune response based on this map. These proteins enable a completely new approach to treating protein-based allergies.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue: $1M to $10M
- Total Funding: 47699997 USD
- Last Funding: 40000000 USD (Series B)
- Funding Status: Early Stage Venture
Technology Stack
Ukko actively uses None products in their tech stack.
Market Presence
Industries: Biotechnology, Food and Beverage, Health Care
Headquarters: Palo Alto, California, United States